Establishment Labs Inc. (ESTA)
Establishment Labs Inc. (ESTA) Stock Price, Analysis & Data
| Bid | 56.45 |
| Market Cap | 2.28B |
| Revenue (ttm) | 245.82M |
| Net Income (ttm) | -38.89M |
| Beta | 1.09 |
| EPS (ttm) | -1.23 |
| PE Ratio (ttm) | n/a |
| Forward PE | 1277 |
| P/B (ttm) | 105.68 |
| P/S (ttm) | 9.29 |
| Earnings Date | Nov 4, 2026 |
| Ask | 97.4 |
| Volume | 405,160 |
| Avg. Volume (20D) | 620,116 |
| Open | 78.89 |
| Previous Close | 79.47 |
| Day's Range | 75.77 - 79.24 |
| 52-Week Range | 36.53 - 97.59 |
| Analyst | Strong Buy |
| Price Target | 105 (37.04%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About ESTA
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through dist...
Financial Performance
In 2025, Establishment Labs's revenue was 211.08M, an increase of 27.14% compared to the previous year's 166.03M. Earnings were -51.06M, a decrease of -39.64%.
Financial StatementsAnalyst Forecast
According to 9 analyst ratings, the average rating for ESTA stock is "Strong Buy". The 12-month stock price forecast is 105, which is upside of 37.04% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
